1. Home
  2. QNCX vs ASMB Comparison

QNCX vs ASMB Comparison

Compare QNCX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • ASMB
  • Stock Information
  • Founded
  • QNCX 2012
  • ASMB 2005
  • Country
  • QNCX United States
  • ASMB United States
  • Employees
  • QNCX N/A
  • ASMB N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNCX Health Care
  • ASMB Health Care
  • Exchange
  • QNCX Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • QNCX 62.0M
  • ASMB 84.5M
  • IPO Year
  • QNCX 2019
  • ASMB 2010
  • Fundamental
  • Price
  • QNCX $1.40
  • ASMB $13.02
  • Analyst Decision
  • QNCX Strong Buy
  • ASMB Buy
  • Analyst Count
  • QNCX 4
  • ASMB 2
  • Target Price
  • QNCX $9.50
  • ASMB $35.00
  • AVG Volume (30 Days)
  • QNCX 126.6K
  • ASMB 22.1K
  • Earning Date
  • QNCX 03-31-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • QNCX N/A
  • ASMB N/A
  • EPS Growth
  • QNCX N/A
  • ASMB N/A
  • EPS
  • QNCX N/A
  • ASMB N/A
  • Revenue
  • QNCX N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • QNCX N/A
  • ASMB $282.16
  • Revenue Next Year
  • QNCX N/A
  • ASMB N/A
  • P/E Ratio
  • QNCX N/A
  • ASMB N/A
  • Revenue Growth
  • QNCX N/A
  • ASMB N/A
  • 52 Week Low
  • QNCX $0.51
  • ASMB $11.05
  • 52 Week High
  • QNCX $2.45
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 36.52
  • ASMB 40.89
  • Support Level
  • QNCX $1.38
  • ASMB $12.10
  • Resistance Level
  • QNCX $1.49
  • ASMB $14.25
  • Average True Range (ATR)
  • QNCX 0.12
  • ASMB 0.60
  • MACD
  • QNCX -0.01
  • ASMB -0.10
  • Stochastic Oscillator
  • QNCX 7.32
  • ASMB 35.11

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: